Nanjing Hicin Pharmaceutical Co., Ltd. (SHE:300584)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceuticals	671.05M	504.36M	517.83M	526.47M	578.32M
Pharmaceuticals Growth	33.05%	-2.60%	-1.64%	-8.97%	-18.12%
Total	671.05M	504.36M	517.83M	526.47M	578.32M
Total Growth	33.05%	-2.60%	-1.64%	-8.97%	-18.12%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Northeast China Region	23.20M	16.55M	19.98M	27.58M	56.56M
Northeast China Region Growth	40.21%	-17.21%	-27.53%	-51.24%	-21.19%
North China	187.39M	108.46M	81.56M	73.47M	80.15M
North China Growth	72.77%	32.98%	11.02%	-8.33%	-12.58%
East China	256.82M	191.31M	220.46M	238.87M	249.78M
East China Growth	34.24%	-13.22%	-7.71%	-4.37%	-25.18%
Southern China	64.35M	48.76M	40.77M	30.93M	32.27M
Southern China Growth	31.96%	19.61%	31.79%	-4.14%	-31.72%
Central China Region	62.59M	47.80M	46.91M	46.24M	53.96M
Central China Region Growth	30.95%	1.90%	1.46%	-14.31%	-17.45%
Northwestern Region	29.86M	24.29M	24.59M	30.74M	31.63M
Northwestern Region Growth	22.94%	-1.22%	-20.03%	-2.80%	11.40%
Southwest Region	46.84M	67.19M	81.71M	74.91M	66.46M
Southwest Region Growth	-30.29%	-17.77%	9.07%	12.72%	1.06%
Unallocated	-	-	1.85M	3.73M	7.52M
Unallocated Growth	-	-	-50.28%	-50.37%	240.42%
Total	671.05M	504.36M	517.83M	526.47M	578.32M
Total Growth	33.05%	-2.60%	-1.64%	-8.97%	-18.12%

Source: S&P Global Market Intelligence.